Paulo Mergulhão, João Gonçalves Pereira, Antero Vale Fernandes, Andriy Krystopchuk, João Miguel Ribeiro, Daniel Miranda, Heloísa Castro, Carla Eira, Juvenal Morais, Cristina Lameirão, Sara Gomes, Dina Leal, Joana Duarte, Leonor Pássaro, Filipe Froes, Ignacio Martin-Loeches
Ventilator-associated pneumonia (VAP) is a prevailing nosocomial infection in critically ill patients requiring invasive mechanical ventilation (iMV). The impact of VAP is profound, adversely affecting patient outcomes and placing a significant burden on healthcare resources. This study assessed for the first time the contemporary VAP epidemiology in Portugal and its burden on the healthcare system and clinical outcomes. Additionally, resource consumption (duration of iMV, intensive care unit (ICU), hospital length of stay (LOS)) and empirical antimicrobial therapy were also evaluated...
March 22, 2024: Antibiotics